Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Davis Todd C Create: Alert

All | News | Filings
Date FiledTypeDescription
02/27/2023 4 Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 17,005 shares @ $0
Granted 46,178 options to buy @ $75.09, valued at $3.5M
12/06/2022 4 Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 132,000 options to buy @ $69.7, valued at $9.2M
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2022 4 Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Disposed of 252,207 shares @ $0
Disposed/sold 22,685 restricted stock units @ $0
Disposed/sold 48,123 options to buy @ $2.93, valued at $141k
Disposed/sold 85,760 options to buy @ $3.66, valued at $313.9k
02/01/2022 4 Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Granted 85,760 options to buy @ $3.66, valued at $313.9k
Granted 15,369 restricted stock units @ $0
Exercised 7,684 restricted stock units @ $0
12/23/2021 4 Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.
Txns: Gifted 1,470 shares @ $0
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2021 4 Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Exercised 2,456 options to buy @ $113.5, valued at $278.8k
08/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2020 4 Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 831 shares @ $0
Granted 2,468 options to buy @ $117.58, valued at $290.2k
06/09/2020 4 Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.
Txns: Granted 65,700 options to buy @ $2.39, valued at $157k
04/30/2020 4 Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.
Txns: Sold 60,000 shares @ $3.275, valued at $196.5k
04/30/2020 3/A Davis Todd C (Director) has filed a Form 3/A on Vaxart, Inc.
11/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
08/15/2019 4 Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Exercised 18,123 restricted stock units @ $0
08/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 835 shares @ $0
Granted 4,071 options to buy @ $113.59, valued at $462.4k
10/15/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/09/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2018 4 Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Converted 416,667 shares @ $0
Converted 75 convertible preferred @ $1.8, valued at $135
08/17/2018 4 Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 5,833 shares @ $239.9289, valued at $1.4M
Sold 3,167 shares @ $239.5, valued at $758.5k
08/16/2018 4 Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Exercised 3,124 restricted stock units @ $0
08/03/2018 4 Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Granted 96,247 restricted stock units @ $0
Granted 48,123 options to buy @ $2.93, valued at $141k
07/03/2018 4/A Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 2,474 options to buy @ $0
06/21/2018 4 Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 493 shares @ $0
Granted 2,474 options to buy @ $76.77, valued at $189.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy